EV / EBITDA společnosti Navidea Biopharmaceuticals Inc
Jaká je hodnota metriky EV / EBITDA společnosti Navidea Biopharmaceuticals Inc?
Hodnota metriky EV / EBITDA společnosti Navidea Biopharmaceuticals Inc je N/A
Jaká je definice metriky EV / EBITDA?
EV/EBITDA je podniková hodnota dělená EBITDA (zisk před odečtením úroků, daní, odpisů a amortizací). Měří nákladnost akcie a používá se k porovnání společností mezi sebou častěji než P/E ratio. Měří cenu, jakou investor zaplatí za pohyb hotovosti ve společnosti.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA společností v sektoru Health Care sektor na NYSEMKT ve srovnání se společností Navidea Biopharmaceuticals Inc
Čemu se věnuje společnost Navidea Biopharmaceuticals Inc?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Firmy s metrikou ev / ebitda podobnou společnosti Navidea Biopharmaceuticals Inc
- Hodnota metriky EV / EBITDA společnosti Amigo PLC je N/A
- Hodnota metriky EV / EBITDA společnosti Surgalign je N/A
- Hodnota metriky EV / EBITDA společnosti Catasys je N/A
- Hodnota metriky EV / EBITDA společnosti Goldhills je N/A
- Hodnota metriky EV / EBITDA společnosti Just Kitchen je N/A
- Hodnota metriky EV / EBITDA společnosti Alternate Health je N/A
- Hodnota metriky EV / EBITDA společnosti Navidea Biopharmaceuticals Inc je N/A
- Hodnota metriky EV / EBITDA společnosti Tombill Mines je N/A
- Hodnota metriky EV / EBITDA společnosti Grand Talents je N/A
- Hodnota metriky EV / EBITDA společnosti CV Sciences je N/A
- Hodnota metriky EV / EBITDA společnosti Angold Resources je N/A
- Hodnota metriky EV / EBITDA společnosti Adamis Pharmaceuticals Corp je N/A
- Hodnota metriky EV / EBITDA společnosti Ovid Therapeutics Inc je N/A